BMI View: Due to its small market size and low per capita pharmaceutical spending, the Guatemalan
pharmaceutical market will continue to attract limited multinational drugmaker investment in 2016.
Generic drugmakers in Latin America will continue to dominate the local ..."
BMI View: The commercial incentives for foreign drugmakers to further expand in Guatemala's
pharmaceutical market are limited by the country's low per capita pharmaceutical spending and subdued
market growth. However, in spite of this, the country will continue to att ..."